A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

@article{Siva2016ARP,
  title={A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)},
  author={Shankar Siva and Tomas Kron and Mathias Bressel and Marion Haas and Tao Mai and Shalini Kavita Vinod and Giuseppe Sasso and Wenchang Wong and Hien Le and Thomas N Eade and Nicholas Hardcastle and Brent Chesson and Daniel Pham and Morten H\oyer and Rebecca Montgomery and David Z. Ball},
  journal={BMC Cancer},
  year={2016},
  volume={16},
  pages={1-8}
}
Stereotactic ablative body radiotherapy (SABR) is emerging as a non-invasive method for precision irradiation of lung tumours. However, the ideal dose/fractionation schedule is not yet known. The primary purpose of this study is to assess safety and efficacy profile of single and multi-fraction SABR in the context of pulmonary oligometastases. The TROG 13… CONTINUE READING